Ionis Pharmaceuticals
IONS
IONS
380 hedge funds and large institutions have $6.8B invested in Ionis Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 122 increasing their positions, 113 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.07% more ownership
Funds ownership: 84.84% → 85.91% (+1.1%)
8% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 113
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
380
Holding in Top 10
5
Calls
$88.4M
Puts
$35M
Top Buyers
| 1 | +$135M | |
| 2 | +$107M | |
| 3 | +$72.7M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$64.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$46M |
Top Sellers
| 1 | -$271M | |
| 2 | -$76M | |
| 3 | -$44.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$41.2M |
| 5 |
Renaissance Technologies
New York
|
-$40.8M |